Pfizer and its UK Supplier Fined by Competitions Authority for Overcharging The NHS
Two pharmaceutical companies, Pfizer and Flynn Pharma, have been fined a total of almost £70 million for overcharging the NHS for epilepsy drug phenytoin sodium. The CMA said that for four years Pfizer charged prices between 780% and 1600% higher than previously, while Flynn charged its customers between 2300% and 2600% more than the prices previously charged by Pfizer.
2022-07-26
没有评论